div class=trans-pagebutton class=gotoPage data-page=1Page 1button div class=trans-imagea href=https:reader040fdocumentsusreader040viewer20220313145c43a3da93f3c34c5f7ebb0bhtml5page1jpg target=_blank img data-url=documentdavid-redfern-economist-pharma-summit-10-february-2011-currently-only-onehtmlpage=1 data-page=1 class=trans-thumb lazyload alt=Page 1: David Redfern - Economist Pharma Summit - 10 February 2011 · Currently only one treatment for RCC recommended by NICE David Redfern - Economist Pharma Summit - 10 February 2011 loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader040fdocumentsusreader040viewer20220313145c43a3da93f3c34c5f7ebb0bhtml5thumbnails1jpg width=140 height=200 adivp pdivdiv class=trans-pagebutton class=gotoPage data-page=2Page 2button div class=trans-imagea href=https:reader040fdocumentsusreader040viewer20220313145c43a3da93f3c34c5f7ebb0bhtml5page2jpg target=_blank img data-url=documentdavid-redfern-economist-pharma-summit-10-february-2011-currently-only-onehtmlpage=2 data-page=2 class=trans-thumb lazyload alt=Page 2: David Redfern - Economist Pharma Summit - 10 February 2011 · Currently only one treatment for RCC recommended by NICE David Redfern - Economist Pharma Summit - 10 February 2011 loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader040fdocumentsusreader040viewer20220313145c43a3da93f3c34c5f7ebb0bhtml5thumbnails2jpg width=140 height=200 adivp pdivdiv class=trans-pagebutton class=gotoPage data-page=3Page 3button div class=trans-imagea href=https:reader040fdocumentsusreader040viewer20220313145c43a3da93f3c34c5f7ebb0bhtml5page3jpg target=_blank img data-url=documentdavid-redfern-economist-pharma-summit-10-february-2011-currently-only-onehtmlpage=3 data-page=3 class=trans-thumb lazyload alt=Page 3: David Redfern - Economist Pharma Summit - 10...